Bioneer A/S is a Danish Contract Research Organization within biotechnology and biomedicine located in Hørsholm, close to Copenhagen. Bioneer A/S is a subsidiary of the Technical University of Denmark and is approved by the Danish Ministry of Higher Education and Innovation as an authorized provider of technological services.
ESR’s in the custody of Bioneer will have access to a technology platform and an infrastructure to perform RNA in situ detection, immunohistochemistry, multiplex detection, epifluorescence and bright field microscopy and whole slide scanning. ESR’s will be trained in state-of-the-art in situ hybridization (ISH) technologies for visualization of RNA-species in cytological and histological samples.
As a medium-sized private research university with global reach, Brandeis University dedicates itself to undergraduate education while making groundbreaking discoveries. Brandeis University campus is located in the suburbs of Boston, a global hub for higher education and innovation. Brandeis faculty are leaders in their fields, as passionate about teaching and mentorship as they are about pushing the boundaries of knowledge. CircRTrain Project leader Sebastian Kadener relocated from Hebrew University of Jerusalem, Israel to Brandeis University during the project. To keep his expertise in the consortium, Brandeis University was added as a Partner to circRTrain.
Founded in 2000, Eurice – European Research and Project Office GmbH provides comprehensive support services for the planning, initiation, and implementation of large international collaborative projects. With its strong background in Intellectual Property and Innovation Management, Eurice helps consortia in Horizon 2020 to develop and implement coherent IP management strategies and supports consortia through dissemination, networking, training, and capacity building activities.
Within circRTrain, Eurice provides IPR training and guidance as part of the network training programme. As a member of a dedicated IPR Board, Eurice will support the circRTrain network with advice on IP/IPR management, assisting in development of exploitation, business and development strategies.
Exosomics Siena is located within Medicine Research Centre of Toscana Life Sciences BioPark in Siena. Our mission is to develop, clinically validate and commercialize exosomes based diagnostic tools that will reduce complexity, time and costs of cancer screening, monitoring and support precision medicine. Exosomics biofluid biopsy is based on detection of specific metabolic markers on tumor-released vesicles and their selective isolation from accessible biofluids such as blood or urine. This approach offers comprehensive advantages over conventional and emerging technologies such as cfDNA and CTCs in terms of low sample consumption, stability, reliability, sensitivity and early detection of actionable genomic alterations.